Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Bristol-Myers Squibb Reports First Quarter Financial Results
April 25, 2019 Off

Bristol-Myers Squibb Reports First Quarter Financial Results

By BusinessWire

Increases First Quarter Revenues 14% to $5.9 Billion Posts First Quarter GAAP EPS of $1.04 and Non-GAAP EPS of $1.10…

April 25, 2019 Off

Global HDAC (histone deacetylase) Inhibitors Market 2019-2023 – High Prevalence of Oncology Indications / High Costs Associated with Treatment – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global HDAC (histone deacetylase) Inhibitors Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The HDAC (histone deacetylase)…

April 25, 2019 Off

Daiichi Sankyo Selects Lead Candidate Built on Zymeworks’ Azymetric™ Bispecific Platform

By BusinessWire

One of three bispecific immuno-oncology therapeutics being developed under the two companies’ collaboration agreements Zymeworks to receive US$3.5 million commercial…

April 25, 2019 Off

Aerie Pharmaceuticals Announces Acceptance of Its Investigational New Drug Application for AR-13503 Sustained Release Implant

By BusinessWire

First-In-Human Clinical Study Will be Initiated Later in Second Quarter 2019 DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical…

April 25, 2019 Off

Exelixis’ Partner Takeda Announces Filing of New Drug Application in Japan for CABOMETYX® (Cabozantinib) for Advanced Renal Cell Carcinoma

By BusinessWire

— Regulatory submission triggers $10 million milestone payment to Exelixis under collaboration and license agreement with Takeda — — Submission…

April 25, 2019 Off

Applied StemCell Therapeutics Cures Hemophilia A in Mice

By BusinessWire

MILPITAS, Calif.–(BUSINESS WIRE)–Applied StemCell, Inc. (ASC), a leading gene-editing company, announced that its therapeutic division (ASC Therapeutics) has cured Hemophilia…

April 25, 2019 Off

MEDISCA Brings LP3 Network’s World-Renowned Hormone Replacement Therapy Event to the United Kingdom

By BusinessWire

LONDON–(BUSINESS WIRE)–After many successful events across the United States, Canada, Brazil, Australia, New Zealand, Malaysia, and the Philippines, Medisca UK…

April 25, 2019 Off

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) – Pipeline Review, H1 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) –…

April 25, 2019 Off

The “One and Done” Era for Orphan Drugs: Evaluate Predicts 12% Growth, Driven by New Technologies, but Benefits Go to Big Pharma

By BusinessWire

Orphan drug sales reach $242bn by 2024, according to EvaluatePharma® Orphan Drug Report 2019 LONDON & BOSTON & TOKYO–(BUSINESS WIRE)–lt;a…

April 25, 2019 Off

Gelesis Awarded $10.6 (€9.4) Million Grant to Support Commercial Manufacturing of PLENITY™

By BusinessWire

PLENITY manufacturing facility will be the first factory to commercially produce medical super-absorbent hydrogels synthesized from naturally derived building blocks…

Posts pagination

Previous 1 … 3,252 3,253 3,254 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine